Innovations, technologies and methodologies in driving drug discovery developme across Asia
Prof Dr Andreas Busch | Bayer Healthcare EC & Head of Global Drug Discovery Bayer Schering Pharma
Andreas has been a memmber of the Bayer HealthCare Executive COmmittee as Head of Pharmaceuticals Reserch since February 2007. He has also been in charge of Research in the Animal Health Division since March 2011.
Andreas has worked at various research institutes in Germany and USA prior to joining the industry. His scientific work has been recognised with the Franz Volhard and a Sir Bernhard Katz Awards.
At this conference, Andreas will share his views on partnerships and collaborations with biotechs and research institutes. Find out how such an alliance can foster innovation and transforamtion in the biopharma industry.
Share this
Appearances at this years' conference:
Conference Day 1: 20 March 2012
@ 09.00
Asia’s role in the pharmaceutical industry’s rapid transformation, changing business models and search for innovation
› Prof Dr Andreas Busch, Bayer Healthcare EC & Head of Global Drug Discovery, Bayer Schering Pharma
@ 11.15
Keynote: Pharmas and biotechs’ future R&D alliances
Pharmaceutical industry faces significant challenges due to healthcare reforms and rising costs for innovation
Partnerships & alliances with biotech companies and research institutions could mitigate the cost-of-innovation crisis and further enhance diversity of innovation
Bayer’s innovation sourcing strategy will be presented
› Prof Dr Andreas Busch, Bayer Healthcare EC & Head of Global Drug Discovery, Bayer Schering Pharma